Fecal Bacterial Communities in treated HIV infected individuals on two antiretroviral regimens

Scientific Reports

Volumn 7, Issue , 2017, Pages

  Pinto Cardoso, Sandra ^a   Lozupone, Catherine ^b   Bricenõ, Olivia ^a   Alva Hernández, Selma ^a   Téllez, Norma ^a   Adriana, Aguilar ^a   Murakami Ogasawara, Akio ^a   Reyes Terán, Gustavo ^a  

^a INSTITUTO NACIONAL DE ENFERMEDADES RESPIRATORIAS   (Mexico)

^b UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; HUMAN IMMUNODEFICIENCY VIRUS PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR;

ADULT; AGED; ANIMAL; BIODIVERSITY; CD4 LYMPHOCYTE COUNT; COMORBIDITY; DISEASE MODEL; DRUG EFFECT; FECES; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGY; INTESTINE FLORA; MALE; MICROBIOLOGY; MIDDLE AGED; VIROLOGY; VIRUS LOAD; YOUNG ADULT;

ADULT; AGED; ANIMALS; ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; BIODIVERSITY; CD4 LYMPHOCYTE COUNT; COMORBIDITY; DISEASE MODELS, ANIMAL; FECES; FEMALE; GASTROINTESTINAL MICROBIOME; HIV INFECTIONS; HIV PROTEASE INHIBITORS; HUMANS; MALE; MIDDLE AGED; REVERSE TRANSCRIPTASE INHIBITORS; VIRAL LOAD; YOUNG ADULT;

EID: 85014745310     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep43741     Document Type: Article

References (47)

1. Deeks, S. G., Tracy, R., Douek, D. C. Systemic effects of inflammation on health during chronic HIV infection. Immunity 39, 633-645 (2013).
2. Siedner, M. J. START or SMART Timing of Antiretroviral Therapy Initiation and Cardiovascular Risk for People With Human Immunodeficiency Virus Infection. Open forum infectious diseases 3, ofw032 (2016).
3. Saylor, D., et al. HIV-associated neurocognitive disorder-pathogenesis and prospects for treatment. Nature reviews. Neurology 12, 234-248 (2016).
4. Havlir, D. V., Currier, J. S. CROI 2015: Complications of HIV Infection and Antiretroviral Therapy. Topics in antiviral medicine 23, 56-65 (2015).
5. West, C. E., et al. The gut microbiota and inflammatory noncommunicable diseases: associations and potentials for gut microbiota therapies. The Journal of allergy and clinical immunology 135, 3-13 (2015).
6. Klatt, N. R., Chomont, N., Douek, D. C., Deeks, S. G. Immune activation and HIV persistence: implications for curative approaches to HIV infection. Immunological reviews 254, 326-342 (2013).
7. Klatt, N. R., Funderburg, N. T., Brenchley, J. M. Microbial translocation, immune activation, HIV disease. Trends in microbiology 21, 6-13 (2013).
8. Lederman, M. M., Funderburg, N. T., Sekaly, R. P., Klatt, N. R., Hunt, P. W. Residual immune dysregulation syndrome in treated HIV infection. Advances in immunology 119, 51-83 (2013).
9. Lozupone, C. A., et al. Alterations in the gut microbiota associated with HIV-1 infection. Cell host & microbe 14, 329-339 (2013).
10. Mutlu, E. A., et al. A compositional look at the human gastrointestinal microbiome and immune activation parameters in HIV infected subjects. PLoS pathogens 10, e1003829 (2014).
11. Vujkovic-Cvijin, I., et al. Dysbiosis of the gut microbiota is associated with HIV disease progression and tryptophan catabolism. Science translational medicine 5, 193ra191 (2013).
12. Nowak, P., et al. Gut microbiota diversity predicts immune status in HIV-1 infection. Aids 29, 2409-2418 (2015).
13. McHardy, I. H., et al. HIV Infection is associated with compositional and functional shifts in the rectal mucosal microbiota. Microbiome 1, 26 (2013).
14. Dinh, D. M., et al. Intestinal microbiota, microbial translocation, systemic inflammation in chronic HIV infection. The Journal of infectious diseases 211, 19-27 (2015).
15. Perez-Santiago, J., et al. Gut Lactobacillales are associated with higher CD4 and less microbial translocation during HIV infection. Aids 27, 1921-1931 (2013).
16. Noguera-Julian, M., et al. Gut Microbiota Linked to Sexual Preference and HIV Infection. EBioMedicine 5, 135-146 (2016).
17. Dillon, S. M., et al. An altered intestinal mucosal microbiome in HIV-1 infection is associated with mucosal and systemic immune activation and endotoxemia. Mucosal immunology 7, 983-994 (2014).
18. Lozupone, C. A., et al. HIV-induced alteration in gut microbiota: Driving factors, consequences, effects of antiretroviral therapy. Gut microbes 5 (2014).
19. Kelley, C. F., et al. The rectal mucosa and condomless receptive anal intercourse in HIV-negative MSM: implications for HIV transmission and prevention. Mucosal immunology, doi: 10. 1038/mi. 2016. 97 (2016).
20. Arumugam, M., et al. Enterotypes of the human gut microbiome. Nature 473, 174-180 (2011).
21. Wu, G. D., et al. Linking long-term dietary patterns with gut microbial enterotypes. Science 334, 105-108 (2011).
22. Yatsunenko, T., et al. Human gut microbiome viewed across age and geography. Nature 486, 222-227 (2012).
23. De Filippo, C., et al. Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa. Proceedings of the National Academy of Sciences of the United States of America 107, 14691-14696 (2010).
24. Macarthur, R. D. Management of noninfectious diarrhea associated with HIV and highly active antiretroviral therapy. The American journal of managed care 19, s238-245 (2013).
25. Dikman, A. E., Schonfeld, E., Srisarajivakul, N. C., Poles, M. A. Human Immunodeficiency Virus-Associated Diarrhea: Still an Issue in the Era of Antiretroviral Therapy. Digestive diseases and sciences 60, 2236-2245 (2015).
26. Montessori, V., Press, N., Harris, M., Akagi, L., Montaner, J. S. Adverse effects of antiretroviral therapy for HIV infection. CMAJ: Canadian Medical Association journal = journal de l'Association medicale canadienne 170, 229-238 (2004).
27. Williams, B., Landay, A., Presti, R. M. Microbiome alterations in HIV infection a review. Cellular microbiology, doi: 10. 1111/cmi. 12588 (2016).
28. Gorvitovskaia, A., Holmes, S. P., Huse, S. M. Interpreting Prevotella and Bacteroides as biomarkers of diet and lifestyle. Microbiome 4, 15 (2016).
29. Mejia-Leon, M. E., Petrosino, J. F., Ajami, N. J., Dominguez-Bello, M. G., de la Barca, A. M. Fecal microbiota imbalance in Mexican children with type 1 diabetes. Scientific reports 4, 3814 (2014).
30. Lozupone, C., Knight, R. UniFrac: a new phylogenetic method for comparing microbial communities. Applied and environmental microbiology 71, 8228-8235 (2005).
31. Landmann, R., et al. Human monocyte CD14 is upregulated by lipopolysaccharide. Infection and immunity 64, 1762-1769 (1996).
32. Sandler, N. G., et al. Plasma levels of soluble CD14 independently predict mortality in HIV infection. The Journal of infectious diseases 203, 780-790 (2011).
33. Funaoka, H., Kanda, T., Fujii, H. [Intestinal fatty acid-binding protein (I-FABP) as a new biomarker for intestinal diseases]. Rinsho byori. The Japanese journal of clinical pathology 58, 162-168 (2010).
34. Zhang, H., et al. Human gut microbiota in obesity and after gastric bypass. Proceedings of the National Academy of Sciences of the United States of America 106, 2365-2370 (2009).
35. Zupancic, M. L., et al. Analysis of the gut microbiota in the old order Amish and its relation to the metabolic syndrome. PloS one 7, e43052 (2012).
36. Lopetuso, L. R., Scaldaferri, F., Petito, V., Gasbarrini, A. Commensal Clostridia: leading players in the maintenance of gut homeostasis. Gut pathogens 5, 23 (2013).
37. Manichanh, C., et al. Reduced diversity of faecal microbiota in Crohn's disease revealed by a metagenomic approach. Gut 55, 205-211, doi: 10. 1136/gut. 2005. 073817 (2006).
38. Sokol, H., et al. Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proceedings of the National Academy of Sciences of the United States of America 105, 16731-16736 (2008).
39. Benus, R. F., et al. Association between Faecalibacterium prausnitzii and dietary fibre in colonic fermentation in healthy human subjects. The British journal of nutrition 104, 693-700 (2010).
40. Machiels, K., et al. A decrease of the butyrate-producing species Roseburia hominis and Faecalibacterium prausnitzii defines dysbiosis in patients with ulcerative colitis. Gut 63, 1275-1283 (2014).
41. Hernandez-Avila, M., et al. Validity and reproducibility of a food frequency questionnaire to assess dietary intake of women living in Mexico City. Salud publica de Mexico 40, 133-140 (1998).
42. Block, G., Wakimoto, P., Jensen, C., Mandel, S., Green, R. R. Validation of a food frequency questionnaire for Hispanics. Preventing chronic disease 3, A77 (2006).
43. Klindworth, A., et al. Evaluation of general 16S ribosomal RNA gene PCR primers for classical and next-generation sequencingbased diversity studies. Nucleic acids research 41, e1 (2013).
44. Kuczynski, J., et al. Using QIIME to analyze 16S rRNA gene sequences from microbial communities. Current protocols in bioinformatics/editoral board, Andreas D. Baxevanis ... [et al.[ Chapter 10, Unit 10 17 (2011).
45. Edgar, R. C. Search and clustering orders of magnitude faster than BLAST. Bioinformatics 26, 2460-2461 (2010).
46. Wang, Q., Garrity, G. M., Tiedje, J. M., Cole, J. R. Naive Bayesian classifier for rapid assignment of rRNA sequences into the new bacterial taxonomy. Applied and environmental microbiology 73, 5261-5267 (2007).
47. Faith, D. P., Baker, A. M. Phylogenetic diversity (PD) and biodiversity conservation: some bioinformatics challenges. Evolutionary bioinformatics online 2, 121-128 (2006).